checkAd
    Startseite > Aktien > Nuvectis Pharma > Nachrichten
    Nuvectis Pharma Aktie
    5,9800
     
    USD
    -2,76 %
    -0,1700 USD
    Letzter Kurs 02:00:00 Nasdaq
    5,9700
     
    USD
    600 STK
    Geldkurs 20.05.24
    5,9800
     
    USD
    100 STK
    Briefkurs 20.05.24
    ISIN: US67080T1088 · WKN: A3C8W7 · SYM: NVCT · USA

    Neueste Nachrichten

    Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
    16.05.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
    07.05.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
    08.04.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
    19.03.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma to Present at the 36th Annual Roth Conference
    15.03.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
    14.03.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
    05.03.24 · globenewswire · Nuvectis Pharma
    Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
    09.02.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
    09.02.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma
    18.12.23 · globenewswire · Nuvectis Pharma
    Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
    08.11.23 · globenewswire · Nuvectis Pharma